Keywords: فعال سازی مجدد; Complement activation; Lectin pathway; Selective inhibiton; Asparaginase; Oncology;
مقالات ISI فعال سازی مجدد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فعال سازی مجدد; Complement; Standardization; Therapeutics; Diagnostic techniques and procedures; Pre-analytic; Quality control; CH50; sC5b-9; Complement activation; Complement diagnostics;
Keywords: فعال سازی مجدد; Complement activation; Acute myocardial infarction; Biomarker; C3d; sC5b9; Alpha-1-acid glycoprotein;
Keywords: فعال سازی مجدد; Red blood cells; Complement activation; Regulation; Hemolysis; Anemia;
Keywords: فعال سازی مجدد; Complement activation; Blastocyst; Organogenesis; Progenitor cells; Placenta; Stem cells;
Keywords: فعال سازی مجدد; Atypical hemolytic uremic syndrome; Thrombotic microangiopathies; Complement activation; Eculizumab;
Keywords: فعال سازی مجدد; Layered double hydroxide; Biosafety; Vascular cells; Cell proliferation and viability; Cell migration; Haemolysis; Complement activation;
Keywords: فعال سازی مجدد; C4d; complement activation; diabetic nephropathy; histological lesions; renal pathology;
Keywords: فعال سازی مجدد; Complement regulatory protein; Complement activation; Cynoglossus semilaevis; Bacterial infection;
Keywords: فعال سازی مجدد; Macrophage scavenger receptor 1; Complement activation; Hepatitis; Neutrophils; Neutrophil elastase; Fibrinogen-like protein 2;
Keywords: فعال سازی مجدد; Subunit vaccine; Dengue; Gold nanoparticles; Vaccine adjuvant; Complement activation;
Keywords: فعال سازی مجدد; ACTH; adrenocorticotropic hormone; ADH; anti-diuretic hormone; AP; alternative pathway; BD; brain dead/brain death; C1-INH; C1 esterase inhibitor; CD59; membrane attack complex-inhibitory protein; CP; classical pathway; CR1; complement receptor 1; CR2; co
Keywords: فعال سازی مجدد; Protein adsorption; Mass spectrometry; Polymer beads; Methacrylic acid; Complement activation;
Keywords: فعال سازی مجدد; Complement activation; Tumor; Antibody; Nanomaterial;
Keywords: فعال سازی مجدد; Neuroinflammation; Blood-brain barrier; β-Hydroxybutyrate; Microglia; Complement activation;
Keywords: فعال سازی مجدد; Biomaterial interfaces; Protein adsorption; Complement activation; Supported lipid bilayer; Quartz crystal microbalance;
Keywords: فعال سازی مجدد; antibody; complement activation; deposition; fibrin; lectin pathway;
Keywords: فعال سازی مجدد; Complement activation; Herpes simplex virus type 1; Herpes simplex encephalitis; Central nervous system infection; Anaphylatoxins;
Keywords: فعال سازی مجدد; Thrombotic thrombocytopenic purpura; Hemolytic uremic syndrome; ADAMTS13; Complement activation; Plasma therapy; Eculizumab;
Keywords: فعال سازی مجدد; Sidestream smoke; Shear stress; Endothelial cells; Complement activation; gC1qR; cC1qR;
Keywords: فعال سازی مجدد; Complement activation; iC3b biomarker; Lateral flow assay; Lupus; Intracerebral hemorrhage (ICH)
Keywords: فعال سازی مجدد; Chronic fatigue syndrome; Genetics; Inflammation; Complement activation; Innate immunity;
Keywords: فعال سازی مجدد; Glycol chitosan nanogel; Cytotoxicity; Apoptosis; Cell cycle; Complement activation; Haemocompatibility
Keywords: فعال سازی مجدد; Complement system; Complement activation; Complement regulation; Complement function; Inflammation; Immune response;
Keywords: فعال سازی مجدد; 5-FU; 5-fluorouracil; API; active pharmaceutical ingredient; ADA; anti-drug antibodies; CSE; control standard endotoxin; CTL; cytotoxic T lymphocytes; CARPA; complement activation-related pseudoallergy; CHAPS; 3-[(3-Cholamidopropyl)dimethylammonio]-1-;
Keywords: فعال سازی مجدد; retinoid visual cycle; retinal pigment epithelium; RPE cell culture; complement activation;
Keywords: فعال سازی مجدد; Fuchs’dystrophy; Corneal endothelium; Complement activation; Aqueous humor
Keywords: فعال سازی مجدد; Polymorphonuclear leukocyte; neutrophil granulocyte; elastase; thrombotic thrombocytopenic purpura; disease activity; complement activation;
Keywords: فعال سازی مجدد; Thrombotic thrombocytopenic purpura; Atypical hemolytic uremic syndrome; ADAMTS13; Complement activation; Diagnosis
Keywords: فعال سازی مجدد; Polymer brushes; Biomaterials-surface engineering; Blood coagulation; Complement activation; Non-fouling surfaces; Antimicrobial surfaces;
Keywords: فعال سازی مجدد; 20; 25; 29; 31; C3α; complement activation; CI; confidence interval; CPB; cardiopulmonary bypass; IL; interleukin; MIF; microphage migration inhibitor factor; PaO2; partial pressure of oxygen in arterial blood; TnI; troponin I;
Keywords: فعال سازی مجدد; Cancer; Cardiopulmonary distress; Complement activation; Polystyrene nanoparticles; Poloxamine 908; Tumour growth;
Keywords: فعال سازی مجدد; aHUS; TTP; ADAMTS13 activity; Complement activation; Thrombotic microangiopathy;
Keywords: فعال سازی مجدد; MEEs; middle ear effusions; Spn; Streptococcus pneumoniae; NTHi; nontypable Haemophilus influenza; IAV; influenza A virus; Otitis media; Complement activation; Factor B; C3; C5a; Cytokine;
Keywords: فعال سازی مجدد; Iron oxide nanoparticles; Complement activation; Biodistribution study; Relaxation time;
Keywords: فعال سازی مجدد; alternative pathway; C3 glomerulopathy; complement activation; hemolytic uremic syndrome; ischemia-reperfusion injury;
In vitro evaluation of the biological activities of IgG in seven Chinese intravenous immunoglobulin preparations
Keywords: فعال سازی مجدد; Intravenous immunoglobulin; Biological activity; Pathogenic antigen; Complement activation; Fcγ-receptors binding;
Coding and Noncoding Variants in CFH Act Synergistically for Complement Activation in Immunoglobulin A Nephropathy
Keywords: فعال سازی مجدد; Immunoglobulin A nephropathy; Complement factor H; Complement activation; Genetic variants;
Dual roles of different redox forms of complement factor H in protecting against age related macular degeneration
Keywords: فعال سازی مجدد; CFH; Complement Factor H; AMD; Age related macular degeneration; BM; Bruch's membrane; β2GPI; Beta-2-Glycoprotein I; TRX-1; Thioredoxin-1; TRX-R; Thioredoxin-1 reductase; NADPH; Nicotinamide adenine dinucleotide phosphate; MAA; Malondialdehyde acetaldehy
A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes
Keywords: فعال سازی مجدد; ABC phenomenon; anti-PEG IgM; Complement activation; Liposome; PEGylation; Terminal functional group;
Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies
Keywords: فعال سازی مجدد; Secondary thrombotic microangiopathy; Complement activation; Relative ADAMTS13 deficiency; In-hospital mortality; Factor H;
Full length articleHemocompatibility studies on a degradable polar hydrophobic ionic polyurethane (D-PHI)
Keywords: فعال سازی مجدد; Biomaterials; Thrombosis; Complement activation; Polyurethane; Platelets; Leukocytes;
Estudio de las variables asociadas a la activación local del complemento en la nefropatÃa IgA idiopática
Keywords: فعال سازی مجدد; Activación del complemento; C4d; Lectina de unión a la manosa; Properdina; NefropatÃa IgA; Complement activation; C4d; Mannose binding lectin; Properdin; IgA nephropathy;
Immunological response to nitroglycerin-loaded shear-responsive liposomes in vitro and in vivo
Keywords: فعال سازی مجدد; Nanomedicine; Drug delivery; Complement activation; Pathway; Metastable liposome; Porcine model; Biophysics; Shear-responsive nano-container;
Iron nanomedicines induce Toll-like receptor activation, cytokine production and complement activation
Keywords: فعال سازی مجدد; Iron nanomedicines; Hypersensitivity-like reactions; Innate immune system; Toll-like receptors; Complement activation; Cytokines;
MicroangiopatÃa trombótica secundaria y eculizumab: una opción terapéutica razonable
Keywords: فعال سازی مجدد; MicroangiopatÃas trombóticas secundarias; Activación del complemento; Eculizumab; Secondary thrombotic microangiopathies; Complement activation; Eculizumab;
Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition
Keywords: فعال سازی مجدد; Complement activation; C5a blockade; Trypsin; Thrombin; Eculizumab; aHUS; atypical hemolytic uremic syndrome; APH50; 50% haemolytic complement activity of alternative pathway; C3N; C3 glomerulonephritis; CH50; 50% haemolytic complement activity of classic
MRI-based methods to detect placental and fetal brain abnormalities in utero
Keywords: فعال سازی مجدد; Placental insufficiency; Fetal brain development; Inflammation; Complement activation; MRI;
Rickettsia conorii is a potent complement activator in vivo and combined inhibition of complement and CD14 is required for attenuation of the cytokine response ex vivo
Keywords: فعال سازی مجدد; CD14; Complement activation; Cytokines; Inflammation; Mediterranean spotted fever; Rickettsia conorii; Spotted fever group;
Anti-complement activity of the Ixodes scapularis salivary protein Salp20
Keywords: فعال سازی مجدد; Complement activation; Complement alternative pathway; Properdin; Ixodes scapularis; Salp20; Salivary protein